WebIonis Pharmaceuticals, Inc. 35,184 followers on LinkedIn. For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with its novel antisense technology. Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by industry-leading … Web12 apr. 2024 · Ionis Pharmaceuticals Stock Up 0.9 %. Shares of Ionis Pharmaceuticals stock opened at $37.23 on Tuesday. Ionis Pharmaceuticals has a 1 year low of $31.46 and a 1 year high of $48.82. The stock has ...
Eugene Schneider - EVP, Chief Clinical Development Officer - Ionis ...
Web11 apr. 2024 · In the last 3 months, 10 analysts have offered 12-month price targets for Ionis Pharmaceuticals. The company has an average price target of $46.1 with a high of $67.00 and a low of $27.00. Below ... Web23 mrt. 2024 · Shares of Ionis Pharmaceuticals ( IONS -0.93%) closed down 21.7% on Tuesday after the biotech's partner Roche Holding ( RHHBY -0.87%) announced plans to stop treating patients with tominersen... raymond bushnoe
Why Ionis Pharmaceuticals Stock Is Down 13% This Week
WebAs an investor, I've closely followed Ionis Pharmaceuticals, Inc. for over 15 years. So, it is personally very exciting that we announced today a significant… Sandy Balkin, Ph.D. on … Web23 dec. 2024 · Ionis Pharmaceuticals, Inc., is headquartered in Carlsbad, California, with offices in Boston, Massachusetts, and Dublin, Ireland. For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with our novel antisense technology. Ionis currently has three marketed … WebIonis Pharmaceuticals, Inc. 4 years 9 months Director biomarker assay research Jan 2024 - Present3 years 4 months Carlsbad, California, … raymond burr winery closed